Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene. (Q48647863)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2002

Language	Label	Description	Also known as
English	Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.	scientific article published in March 2002

Statements

scholarly article

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene. (English)

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

1 reference

based on heuristic

inferred from title

Terrance G Johns

object named as

Terrance G Johns

1

0 references

3

object named as

Gerd Ritter

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

12

object named as

Lloyd J Old

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

Elisabeth Stockert

2

object named as

Elisabeth Stockert

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

14

object named as

Andrew M Scott

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

Antony W Burgess

13

object named as

Antony W Burgess

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

10

object named as

Edouard C Nice

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

Webster K Cavenee

6

object named as

Webster K Cavenee

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

author name string

Achim A Jungbluth

4

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

H-J Su Huang

5

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

Fiona E Smyth

7

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

Cathrine M Hall

8

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

Nadine Watson

9

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

William J Gullick

11

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

International Journal of Cancer

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

98

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

3

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

398-408

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Structural alterations of the epidermal growth factor receptor gene in human gliomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Specific targeting of a mutant, activated FGF receptor found in glioblastoma using a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Novel anti-cancer agents in development: exciting prospects and new challenges

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

In vitro and in vivo behavior of radiolabeled chimeric anti-EGFRvIII monoclonal antibody: comparison with its murine parent

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Regulated migration of epidermal growth factor receptor from caveolae

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Monoclonal antibody drug conjugates in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

A new era for radiolabeled antibodies in cancer?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.10189

21 January 2018

Identifiers

10.1002/IJC.10189

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

1 reference

Europe PubMed Central

13 February 2018

http://europepmc.org/abstract/MED/11920591

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48647863&oldid=1743123208"